We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Failure to Dephosphorylate Tau Proteins Leads to Alzheimer's Disease

By Biotechdaily staff writers
Posted on 12 Aug 2003
Researchers have shown that Pin1 (prolyl isomerase) is pivotal in protecting against age-dependent neurodegeneration due to its ability to dephosphorylate tau proteins, a finding that provides insight into the pathogenesis and treatment of Alzheimer's disease and other tauopathies.

In healthy brains, tau proteins serve to assemble and support the "scaffolding” systems that give neurons their structure and function. More...
Phosphates are routinely added and removed from tau. However, in certain neurodegenerative conditions, such as Alzheimer's disease, excess phosphate molecules cause the protein to change shape and cluster into fibers that become tangled and knotted, forming rigid structures that eventually lead to the destruction of the affected neurons in certain regions of the brain, resulting in symptoms of dementia.

In a study published in the July 31, 2003, issue of Nature, investigators at Harvard Medical School (Boston, MA, USA) reported they had developed a knockout mouse lacking the gene for Pin1. These animals suffered progressive age-dependent neuropathy characterized by motor and behavioral deficits, tau hyperphosphorylation, tau filament formation and neuronal degeneration. In addition, the researchers compared Pin1 expression profiles in different brain regions of both healthy individuals and patients with Alzheimer's disease.


"Our findings showed that Pin1expression inversely correlates with neuronal vulnerability to degeneration in normal brains and with the actual formation of tangles in patients with Alzheimer's,” explained senior author Dr. Kun Ping Lu, associate professor of medicine at Harvard Medical School. "Furthermore, we found that in the Pin1 knockout mouse, the removal of the Pin1 gene alone was sufficient to cause many age-dependent neurodegenerative changes. We have now shown that Pin1 plays a pivotal role in protecting against age-dependent neurodegeneration. This makes a convincing case that this enzyme should be taken into consideration in future studies of Alzheimer's disease.”




Related Links:
Harvard Medical School

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.